Day: March 18, 2024
Adverum Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Pipeline Highlights and Corporate Updates
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Eyenovia Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Motus GI Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Augmedix Delivers 45% Revenue Growth and Expanded Gross Margins for Fourth Quarter of 2023
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Red Cat Holdings Reports Financial Results for Fiscal Third Quarter 2024 and Provides Corporate Update
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
dLocal Reports 2023 Fourth Quarter and Full year Financial Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Orchard Therapeutics Receives FDA Approval of Lenmeldy™ (atidarsagene autotemcel), the Only Therapy for Eligible Children with Early-onset Metachromatic Leukodystrophy in the U.S.
Written by Customer Service on . Posted in Public Companies.